Koninklijke DSM NV
AEX:DSM
Koninklijke DSM NV
Note Receivable
Koninklijke DSM NV
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Koninklijke DSM NV
AEX:DSM
|
Note Receivable
€160m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Corbion NV
AEX:CRBN
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel NV
AEX:AKZA
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Koninklijke DSM NV
Glance View
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
See Also
What is Koninklijke DSM NV's Note Receivable?
Note Receivable
160m
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Note Receivable amounts to 160m EUR.
What is Koninklijke DSM NV's Note Receivable growth rate?
Note Receivable CAGR 5Y
-15%
Over the last year, the Note Receivable growth was 400%. The average annual Note Receivable growth rates for Koninklijke DSM NV have been 14% over the past three years , -15% over the past five years .
